Tumour Models Nordics, Stockholm, Sweden, April 9-10, 2025

Conference

Event
-
April 9, 2025

genOway's presentation on Wednesday, 9 April, 2025 | 2:15 p.m. CEST:

Assessment of translational tumor biology and efficacy in humanized mouse models:

  • Outlining genO-BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
  • Investigating human immune cell recruitment into tumor microenvironment
  • Examining the functionality of myeloid cells and their contribution to translatable safety assessment of therapies
  • Showcasing a mouse model expressing human Fc receptors as tools for translational assessment of Fc receptor-targeted therapies

Tumour Models Nordics, Stockholm, Sweden, April 9-10, 2025

Get in touch

Let us know how we can help

Other news & events

AACR Annual Meeting 2026, San Diego, CAL, April 17-22
Conference
genOway presentation
Event
-
Feb 2026
Read on
Revolutionizing the Prediction of Antibody Therapies in Humans with a Unique Mouse Model
Partnership
News
-
Feb 2026
Read on
NextGen Biomed 2026, London, UK, March 24-25
Conference
Event
-
Feb 2026
Read on
10th Tumor Models Summit San Francisco, January 28-29, 2026
Conference
genOway presentation
Event
-
Jan 2026
Read on
genOway Shanghai at ICAR 2026 in Shanghai
Conference
Event
-
Jan 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe